Perspectives on CPT: A Real‐World Evidence Framework for Optimising Dosing in All Patients with COVID‐19

A COVID-19 call to action in Clinical Pharmacology & Therapeutics from Richard Peck, Daniel Weiner, Jack Cook and Bob Powell.

“The Global Heads of Clinical Pharmacology from the pharmaceutical companies developing potential treatments should meet together with representatives from organisations interested in becoming trusted third parties and key regulatory and academic opinion leaders to agree the principles for model and de-identified data sharing and how to establish the necessary infrastructure.”

https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1922

 

Leave a Reply

Your email address will not be published. Required fields are marked *